Private Trust Company’s Abiomed Inc ABMD Stock Holding History

Private Trust Company’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-46	Closed	-$11K	–	2310
2022 Q3	$11K	Sell	46 -3	-6%	-$810	﹤0.01%	1434
2022 Q2	$12K	Buy	+49	New	+$13.2K	﹤0.01%	1436

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Private Trust Company's ABMD Position: Q4 2022 in Review

Private Trust Company sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 46 shares — an estimated $11K sold.

Private Trust Company first reported a position in ABMD in Q2 2022 and held it in 2 quarters. The position peaked at $12K in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Private Trust Company reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Private Trust Company sold 46 Abiomed Inc shares in Q4 2022, an estimated $11K.
Private Trust Company first reported a position in Abiomed Inc in Q2 2022 and held it in 2 quarters.
Private Trust Company's Abiomed Inc position peaked at $12K in Q2 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Private Trust Company's 13F filing for Q4 2022, filed 18 Jan 2023.